Richard Aldrich, Director at CONCERT PHARMACEUTICALS, INC. (CNCE), sold 21,108 shares at $21.36 ($434K) on 2018-01-29, disclosed to the SEC on 2018-01-29.
Open-market sale of $434k CNCE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.22 | 3,054 | $62K | 14.2% |
| 2 | $20.22 | 3,054 | $62K | 14.2% |
| 3 | $20.31 | 5,000 | $102K | 23.4% |
| 4 | $20.46 | 5,000 | $102K | 23.6% |
| 5 | $21.36 | 5,000 | $107K | 24.6% |
| Total | $20.57 avg | 21,108 |
| $434K |
| 100% |
| Filing → |
| CNCE | SELL | 2018-02-01 | $356K | — | Filing → |
| CNCE | SELL | 2018-01-24 | $689K | — | Filing → |
| CNCE | SELL | 2018-01-19 | $580K | — | Filing → |